CELEBRATING HER APPOINTMENT AT CBSET... Ellie joined CBSET in July 2024 as a Study Director. She was previously a postdoctoral associate at the University of Minnesota’s Department of Neurology (2021-24) and its Division of Infectious Disease (2020-21), piloting preclinical research and clinical development of advanced gene therapies.
THINGS YOU SHOULD KNOW ABOUT ELLIE KHADIR
She is an expert in small- and large-animal disease models.
Dr. Khadir has co-authored peer-reviewed articles on topics ranging from systemic gene therapy to disease modeling and therapeutic development. As a Study Director for CBSET, she is actively involved in the evaluation of new medical therapies. “My roles include directing preclinical studies and supporting our study-director team. Collectively, we direct preclinical studies evaluating the safety and efficacy of medical devices, cell-based therapies, and pharmaceuticals,” she says. “I was particularly interested in joining CBSET because of its leadership position as a preclinical translational research institute. CBSET is well-known for providing a multidisciplinary approach to our services through unbiased scientific advice, extensive regulatory expertise, and a mission to understand how mechanisms of action can be applied to support product differentiation — all of which, when combined, creates an innovative and iterative approach to accelerating clinical development.”
She is an experienced translational scientist and veterinarian.
As a postdoctoral associate at the University of Minnesota’s Department of Neurology immediately prior to joining CBSET, Dr. Khadir lead in vivo and in vitro research that supported clinical development of advanced gene therapies for rare genetic diseases, focused on restoring the function of muscles and the nervous system. Previously, at the University’s Division of Infectious Disease, she conducted research in synthetic and molecular virology, specifically studying the entry process of HIV-1 and developing a COVID-19 vaccine using spike protein and a library of mutations. Her core skills include rodent and large-animal surgery, drug administration, and clinical trials. In addition, Dr. Khadir is an expert at in vivo pharmacological models, biomarker identification, and PK/PD analysis. Her scientific publications have appeared in a variety of peer-reviewed journals including PLos Neglected Tropical Diseases and Journal of Translational Medicine, among others. She holds a PhD in Anatomical Pathology and is a Doctor of Veterinary Medicine.